Skip to main content

Lynch Syndrome

2
Pipeline Programs
6
Companies
5
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

6 companies ranked by most advanced pipeline stage

Sofie
SofieVA - Dulles
1 program
1
MesalaminePhase 21 trial
Active Trials
NCT04920149Recruiting150Est. Sep 2045
Medtronic
MedtronicNJ - Phillipsburg
1 program
1
Capsule endoscopyPhase 11 trial
Active Trials
NCT00898768Completed200Est. Dec 2014
FUJIFILM Pharma
FUJIFILM PharmaMA - Cambridge
1 program
ColonoscopyN/A1 trial
Active Trials
NCT03344289Completed357Est. Jun 2020
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Let's Talk Genetics ProvidersN/A
Genome & Company
Genome & CompanyKorea - Suwon
1 program
Let's Talk Genetics ProvidersN/A1 trial
Active Trials
NCT07304063Not Yet Recruiting20Est. Oct 2026
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
Lynch Syndrome Integrative Epidemiology and GeneticsN/A1 trial
Active Trials
NCT06582914Recruiting5,000Est. Dec 2054

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
SofieMesalamine
MedtronicCapsule endoscopy
Genome & CompanyLet's Talk Genetics Providers
Colorado TherapeuticsLynch Syndrome Integrative Epidemiology and Genetics
FUJIFILM PharmaColonoscopy

Clinical Trials (5)

Total enrollment: 5,727 patients across 5 trials

NCT04920149SofieMesalamine

Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome

Start: Mar 2022Est. completion: Sep 2045150 patients
Phase 2Recruiting
NCT00898768MedtronicCapsule endoscopy

Capsule Endoscopy to Screen for Small Bowel Neoplasia in Lynch Syndrome

Start: May 2009Est. completion: Dec 2014200 patients
Phase 1Completed
NCT07304063Genome & CompanyLet's Talk Genetics Providers

Overcoming Barriers to Uptake of Cascade Screening

Start: May 2026Est. completion: Oct 202620 patients
N/ANot Yet Recruiting
NCT06582914Colorado TherapeuticsLynch Syndrome Integrative Epidemiology and Genetics

Lynch Syndrome Integrative Epidemiology and Genetics

Start: Oct 2024Est. completion: Dec 20545,000 patients
N/ARecruiting
NCT03344289FUJIFILM PharmaColonoscopy

Linked Color Imaging Versus High-definition White Light Endoscopy for the Detection of Polyps in Patients With Lynch Syndrome (LCI-LYNCH)

Start: Jan 2018Est. completion: Jun 2020357 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 5,727 patients
6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.